GFM Network News


U.S. approves marijuana-derived drug for epilepsy

Reuters — The U.S. health regulator approved GW Pharmaceuticals’ epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the country and opening floodgates for more research into the medicinal properties of cannabis. The drug’s approval permits its use in patients aged two years and older with Dravet Syndrome (DS) and […] Read more